A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
for Myelofibrosis
Sites in Los Angeles, Duarte +28 more locations
Sponsor: Sumitomo Pharma America, Inc.
Sex: All·Age: 18+
Code: NCT04176198·Phase 1, Phase 2·Recruiting·Listed Nov 2019